The Patent Finder

Acetylon Pharmaceuticals, Inc.

21 patents currently held · Updated Nov 15, 2026
9 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 3 name spellings.

0
Ending by 2030
Jan 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 6, 2026
    The maintenance fee for Pharmaceutical combinations comprising a histone deacetylase inhibitor and a BCL-2 inhibitor and methods of use thereof (US 11,666,568) comes due Dec 6, 2026. Unpaid by Jun 7, 2027, it lapses early.
  • 1 fee due Feb 6, 2027
    The maintenance fee for Phenyl and pyridinyl hydroxamic acids (US 10,370,324) comes due Feb 6, 2027. Unpaid by Aug 6, 2027, it lapses early.
  • 1 fee due May 5, 2027
    The maintenance fee for Crystalline forms of a histone deacetylase inhibitor (US 10,464,906) comes due May 5, 2027. Unpaid by Nov 5, 2027, it lapses early.
  • 1 fee due Jul 16, 2027
    The maintenance fee for Pharmaceutical combinations comprising a histone deacetylase inhibitor and an aurora kinase inhibitor and methods of use thereof (US 11,872,227) comes due Jul 16, 2027. Unpaid by Jan 18, 2028, it lapses early.
  • 1 fee due Sep 8, 2027
    The maintenance fee for Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors (US 9,278,963) comes due Sep 8, 2027. Unpaid by Mar 8, 2028, it lapses early.
  • 1 fee due Nov 12, 2027
    The maintenance fee for Biomarkers to identify patients that will respond to treatment and treating such patients (US 10,648,038) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,148,526Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,394,810Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,617,750Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,614,223Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,409,890Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,648,038Biomarkers to identify patients that will respond to treatment and treating such patients
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,663,825Biomarkers to identify patients that will respond to treatment and treating such patients
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,403,779Combinations of histone deacetylase inhibitors and either Her2 inhibitors or PI3K inhibitors
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,278,963Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,722,512Combinations of histone deacetylase inhibitors and either HER2 inhibitors or PI3K inhibitors
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 21 patents shown.
Pro members see all 21.
Pro members: see all 21 patents
Also on record, not counted in the 21: 9 patents in force now held by others · 17 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 abandoned · 16 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited